multiple dose bioequivalence study [Design Issues]

posted by Loky do – Egypt, 2020-08-09 13:50 (1772 d 09:57 ago) – Posting: # 21842
Views: 4,112

Dears

If we have solifenacin 6 mg (immediate-release) / tamsulosin 0.4 mg modified-release product combination, is multiple-dose bioequivalence study required to be submitted to the European authorities in addition to fast & fed studies, as there is no specific guidance for this product & in GCC region fast & fed studies only accepted.

Thanks in advance

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
19 visitors (0 registered, 19 guests [including 13 identified bots]).
Forum time: 23:48 CEST (Europe/Vienna)

Law is mind without reason.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5